In Depth Research on Transdermal Patch Market & Pipeline Insight 2015

“Transdermal Patch Market & Pipeline Insight 2015” Report Highlights:

* Mechanism of Transdermal Patch Drug Delivery
* Global Transdermal Patch Market Outlook
* Transdermal Patch Clinical Pipeline by Company, Indication & Phase
* Transdermal Patches in Clinical Pipeline: 93
* Marketed Transdermal Patches: 51
* Global Transdermal Patch Market Future Prospects

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Transdermal-Patch-Market-&-Pipeline-Insight-2015.php

Table of Contents

1. Introduction to Transdermal Patch

2. Types of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

3. Mechanism of Transdermal Patch Drug Delivery

4. Advantages of Transdermal Patch

5. Global Transdermal Patch Market Outlook
5.1 Current Market Scenario
5.2 Regional Trends
5.3 Transdermal Patch Clinical Pipeline Overview

6. Global Transdermal Patch Market Dynamics
6.1 Favorable Market Parameters
6.2 Commercialization Challenges

7. Global Transdermal Patch Market Future Prospects

8. Global Transdermal Patch Clinical Pipeline by Company, Indication & Phase
8.1 Unknown
8.2 Research
8.3 Preclinical
8.4 Clinical
8.5 Phase-I
8.6 Phase-I/II
8.7 Phase-II
8.8 Phase-III
8.9 Preregistration
8.10 Registered

9. Marketed Transdermal Patch by Company & Indication

10. Suspended & Discontinued Transdermal Patch Clinical Pipeline by Company, Indication & Phase
10.1 No Development Reported
10.2 Discontinued
10.3 Market withdrawal
10.4 Suspended

11. Competitive Landscape
11.1 3M Pharmaceuticals
11.2 Actavis
11.3 Ethical Holdings
11.4 GalaxoSmithKline
11.5 Johnson & Johnson
11.6 Novartis
11.7 Pfizer
11.8 Proctor & Gamble
11.9 ProStrakan
11.10 UCB pharmaceuticals
11.11 Vaxxas pharmaceutical

Figure 1-1: Steps Involved in Transdermal Permeation
Figure 1-2: Ideal Properties of Transdermal Patch
Figure 2-1: Types of Commercially Available Transdermal Patch
Figure 3-1: Properties of Transdermal Therapeutics
Figure 3-2: Components of Transdermal Patch
Figure 3-3: Types of Permeation Enhancers
Figure 3-4: Schematic Representation of Iontophoresis
Figure 3-5: Mechanism of Scopolamine Transdermal Patch
Figure 3-6: Mechanism of Nicotine Transdermal Patch
Figure 3-7: Mechanism of Female Contraceptive Transdermal Patch
Figure 4-1: Issues with Traditional Drug Delivery Methods
Figure 4-2: Advantages of Transdermal Patch
Figure 4-3: Consistent Drug Supply by Transdermal Patch
Figure 5-1: Transdermal Patch Clinical Pipeline by Phase (%), 2015
Figure 5-2: Transdermal Patch Clinical Pipeline by Phase (Number), 2015
Figure 5-3: No Development Reported in Transdermal Patch Clinical Pipeline by Phase (%), 2015
Figure 5-4: No Development Reported in Transdermal Patch Clinical Pipeline by Phase (Number), 2015
Figure 5-5: Discontinued Transdermal Patch Clinical Pipeline by Phase (%), 2015
Figure 5-6: Discontinued Transdermal Patch Clinical Pipeline by Phase (Number), 2015
Figure 6-1: Drivers for Transdermal Patch
Figure 6-2: Transdermal Patch Market Commercialization Challenges

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.